Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.

Ahmad S, Mokaddas E, Al-Mutairi N, Eldeen HS, Mohammadi S.

PLoS One. 2016 Apr 20;11(4):e0153563. doi: 10.1371/journal.pone.0153563. eCollection 2016.

2.

Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.

Rahman A, Sahrin M, Afrin S, Earley K, Ahmed S, Rahman SM, Banu S.

PLoS One. 2016 Apr 7;11(4):e0152694. doi: 10.1371/journal.pone.0152694. eCollection 2016.

3.

Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.

Brossier F, Guindo D, Pham A, Reibel F, Sougakoff W, Veziris N, Aubry A.

J Clin Microbiol. 2016 Jun;54(6):1573-80. doi: 10.1128/JCM.00051-16. Epub 2016 Apr 6.

PMID:
27053671
4.

Drug Resistance Mechanisms in Mycobacterium tuberculosis.

Palomino JC, Martin A.

Antibiotics (Basel). 2014 Jul 2;3(3):317-40. doi: 10.3390/antibiotics3030317. Review.

5.

Compensatory Mutations of Rifampin Resistance Are Associated with Transmission of Multidrug-Resistant Mycobacterium tuberculosis Beijing Genotype Strains in China.

Li QJ, Jiao WW, Yin QQ, Xu F, Li JQ, Sun L, Xiao J, Li YJ, Mokrousov I, Huang HR, Shen AD.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2807-12. doi: 10.1128/AAC.02358-15. Print 2016 May.

PMID:
26902762
6.

The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates.

Tomasicchio M, Theron G, Pietersen E, Streicher E, Stanley-Josephs D, van Helden P, Warren R, Dheda K.

Sci Rep. 2016 Feb 10;6:17850. doi: 10.1038/srep17850.

7.

Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform.

Starks AM, Avil├ęs E, Cirillo DM, Denkinger CM, Dolinger DL, Emerson C, Gallarda J, Hanna D, Kim PS, Liwski R, Miotto P, Schito M, Zignol M.

Clin Infect Dis. 2015 Oct 15;61Suppl 3:S141-6. doi: 10.1093/cid/civ610.

PMID:
26409275
8.

Comparison and development of pyrazinamide susceptibility testing methods for tuberculosis in Thailand.

Foongladda S, Klayut W, Pholwat S, Houpt E.

Diagn Microbiol Infect Dis. 2015 Nov;83(3):270-3. doi: 10.1016/j.diagmicrobio.2015.07.008. Epub 2015 Jul 17.

PMID:
26298819
9.

Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence Setting.

Strydom K, Ismail F, Matabane MM, Onwuegbuna O, Omar SV, Ismail N.

J Clin Microbiol. 2015 Sep;53(9):3032-4. doi: 10.1128/JCM.01691-15. Epub 2015 Jul 1.

10.

Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.

Willby M, Sikes RD, Malik S, Metchock B, Posey JE.

Antimicrob Agents Chemother. 2015 Sep;59(9):5427-34. doi: 10.1128/AAC.00662-15. Epub 2015 Jun 22.

11.

Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.

Ramirez-Busby SM, Valafar F.

Antimicrob Agents Chemother. 2015 Sep;59(9):5267-77. doi: 10.1128/AAC.00204-15. Epub 2015 Jun 15. Review.

12.

Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results.

Li H, Kayani Mu, Gu Y, Wang X, Zhu T, Duan H, Ma Y, Huang H, Javid B.

J Clin Microbiol. 2015 Aug;53(8):2781-4. doi: 10.1128/JCM.00891-15. Epub 2015 Jun 10.

13.

Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing.

Colman RE, Schupp JM, Hicks ND, Smith DE, Buchhagen JL, Valafar F, Crudu V, Romancenco E, Noroc E, Jackson L, Catanzaro DG, Rodwell TC, Catanzaro A, Keim P, Engelthaler DM.

PLoS One. 2015 May 13;10(5):e0126626. doi: 10.1371/journal.pone.0126626. eCollection 2015.

14.

Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside Resistance.

Roh SS, Smith LE, Lee JS, Via LE, Barry CE 3rd, Alland D, Chakravorty S.

PLoS One. 2015 May 4;10(5):e0126257. doi: 10.1371/journal.pone.0126257. eCollection 2015.

15.

Outcomes and use of therapeutic drug monitoring in multidrug-resistant tuberculosis patients treated in virginia, 2009-2014.

Heysell SK, Moore JL, Peloquin CA, Ashkin D, Houpt ER.

Tuberc Respir Dis (Seoul). 2015 Apr;78(2):78-84. doi: 10.4046/trd.2015.78.2.78. Epub 2015 Apr 2.

16.

Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.

Avalos E, Catanzaro D, Catanzaro A, Ganiats T, Brodine S, Alcaraz J, Rodwell T.

PLoS One. 2015 Mar 27;10(3):e0120470. doi: 10.1371/journal.pone.0120470. eCollection 2015. Review.

17.

A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics.

Wlodarska M, Johnston JC, Gardy JL, Tang P.

Clin Microbiol Rev. 2015 Apr;28(2):523-39. doi: 10.1128/CMR.00124-14. Review.

18.

Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.

Seifert M, Catanzaro D, Catanzaro A, Rodwell TC.

PLoS One. 2015 Mar 23;10(3):e0119628. doi: 10.1371/journal.pone.0119628. eCollection 2015. Review.

19.

Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosis.

Yakrus MA, Metchock B, Starks AM.

Tuberc Res Treat. 2015;2015:701786. doi: 10.1155/2015/701786. Epub 2015 Feb 22.

20.

Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis.

Salamon H, Yamaguchi KD, Cirillo DM, Miotto P, Schito M, Posey J, Starks AM, Niemann S, Alland D, Hanna D, Aviles E, Perkins MD, Dolinger DL.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S50-7. doi: 10.1093/infdis/jiu816. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk